Edition:
United States

Pfizer Inc (PFE)

PFE on New York Consolidated

31.77USD
20 Jan 2017
Change (% chg)

$0.07 (+0.22%)
Prev Close
$31.70
Open
$31.72
Day's High
$32.12
Day's Low
$31.66
Volume
30,159,695
Avg. Vol
24,886,288
52-wk High
$37.39
52-wk Low
$28.25

PFE

Chart for PFE

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products. The Company's segments include Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). Its biopharmaceutical products include Lipitor, Sutent and the... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $192,791.59
Shares Outstanding(Mil.): 6,068.35
Dividend: 0.32
Yield (%): 4.03

Financials

  PFE Industry Sector
P/E (TTM): 31.72 29.51 30.38
EPS (TTM): 1.00 -- --
ROI: 4.34 15.44 14.86
ROE: 9.51 16.62 16.28

Sanofi's M&A misses frustrate some investors in drugmaker

PARIS/DAVOS, Switzerland For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker.

Jan 20 2017

INSIGHT-Sanofi's M&A misses frustrate some investors in drugmaker

* Investors growing impatient after it fails to land acquisitions

Jan 20 2017

Trump nominee spreads insider-trading disease

WASHINGTON (Reuters Breakingviews) - One of Donald Trump's nominees is spreading the insider-trading disease. Georgia Representative Tom Price, tapped to be U.S. health and human services secretary, has raised new conflicts-of-interest concerns. He bought shares in publicly traded companies while working on bills affecting them.

Jan 17 2017

BlackRock CEO says Trump 'tax holiday' may do little for U.S. growth: CNBC

NEW YORK BlackRock Inc CEO Larry Fink on Friday criticized a policy backed by U.S. President-elect Donald Trump to entice U.S. companies to bring their swelling overseas cash piles home, saying a tax holiday may do little to boost growth.

Jan 13 2017

BlackRock CEO says Trump 'tax holiday' may do little for U.S. growth -CNBC

NEW YORK, Jan 13 BlackRock Inc CEO Larry Fink on Friday criticized a policy backed by U.S. President-elect Donald Trump to entice U.S. companies to bring their swelling overseas cash piles home, saying a tax holiday may do little to boost growth.

Jan 13 2017

Investors in big pharma, biotech look to ride out Trump storm

NEW YORK Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new products to help ride out a storm of political uncertainty as the incoming Trump administration dives into healthcare policy.

Jan 12 2017

Investors in big pharma, biotech look to ride out Trump storm

NEW YORK, Jan 12 Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new products to help ride out a storm of political uncertainty as the incoming Trump administration dives into healthcare policy.

Jan 12 2017

Growth hormone deficiency drug from OPKO and Pfizer fails study

OPKO Health Inc said its experimental drug for growth hormone deficiency (GHD) in adults failed to provide a statistically significant benefit over a placebo in a late-stage study, sending its shares down about 17 percent on Friday.

Dec 30 2016

FDA rejects Cempra's antibiotic for pneumonia, shares sink

Cempra Inc said on Thursday the U.S. Food and Drug Administration had rejected its antibiotic for community-acquired bacterial pneumonia (CABP), citing inadequate data on the drug's impact on the liver and manufacturing issues.

Dec 29 2016

Arizona agrees to drop use of contested sedative in executions

Arizona has reached an agreement with lawyers for death row inmates that would prohibit a sedative that has been used in executions by lethal injection that took longer than usual or were botched in several states.

Dec 21 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $114.15 -0.05
Novartis AG (NOVN.S) CHF70.90 -0.20
Merck & Co., Inc. (MRK.N) $62.53 +2.20
Roche Holding Ltd. (ROG.S) CHF233.50 +0.50
Roche Holding Ltd. (RO.S) CHF236.10 +0.10
Abbott Laboratories (ABT.N) $40.46 +0.06
Bayer AG (BAYGn.DE) €102.50 +0.60
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €75.62 -0.15
AstraZeneca plc (AZN.L) 4,318.50 -150.00

Earnings vs. Estimates